Patient Buzz: The Mind-Skin Connection | The Expert Weighs In
PsychodermatologyStylecaster recently posted an online article about psychodermatology. How do the mind and skin influence each other? What do we now know and what questions are still unanswered? How can dermatology clinicians best counsel their patients when the mind-skin connection is at work? For expert advice, I reached out to Steven Daveluy, MD, FAAD, associate professor and program director at Wayne St …
Psychodermatology
Patient Buzz: Hair Growth Treatments | The Expert Weighs In
Hair Growth TreatmentsGlamour recently posted an online article about how to grow hair faster. Does research support the use of supplements for hair growth? How quickly can patients expect to see results from any hair interventions? For expert advice, I reached out to Amy McMichael, MD, FAAD, professor and chair of the department of dermatology at Wake Forest University School of Medicine. When a patient asks how …
Hair Growth Treatments
Approach to Treating Hidradenitis Suppurativa in Patients with Skin of Color: Insights from Dr. Ginette A. Okoye
Hidradenitis Suppurativa (HS) is a challenging dermatological condition characterized by painful, recurrent, and often disfiguring skin lesions. In this article, we will explore the expert insights of Dr. Ginette Okoye, Professor and Chair of the Howard University Department of Dermatology, as she discussed her approach to and experience with treating patients with HS at the 2023 Skin of Color Upd …
Friday Pop Quiz #243
The correct answer is B. About 20% of patients will have a long-term disease that results in enthesitis and destructive arthritis. The patient has reactive arthritis (formerly known as Reiter's syndrome). Reactive arthritis is a chronic inflammatory disease similar to psoriasis with psoriatic arthritis and is thought to be a variant form. The classic triad includes urethritis, conjunctiviti …
JDD October 2023 Issue Highlights | Special Topic: Atopic Dermatitis
atopic dermatitisThe October 2023 issue of the Journal of Drugs in Dermatology (JDD) focuses on atopic dermatitis and features mix of original articles, letters to the editor, and case reports. Among many of the topics explored in this issue are statins for treating actinic porokeratosis, ant venom-based ceramide therapy, the psychosocial burden of skin disease among skin of color consumers, treatment of lichen pl …
atopic dermatitis
error

Enjoy this blog? Please spread the word :)